Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Personal Protective Technology Laboratory (NPPTL)


Facebook
        Twitter
        LinkedIn
        Syndicate





NIOSH Conformity Assessment Letter to Manufacturers										Related Pages
										**Subject:** Effective Immediately – NIOSH fraud and fraudulent statements policy and new information about using NIOSH marks
This notice and NIOSH CA 2022-1040 supersede NIOSH CA 2021-1032NIOSH CA 2022-1041
February 2022
This NIOSH Fraud and Fraudulent Statements Policy was first included in the February 2021 Conformity Assessment Letter to Manufacturers (NIOSH CA 2021-1032). That notice also offered prioritization guidance and is now superseded by this notice NIOSH CA 2022-1041 (fraud and fraudulent statements) and NIOSH CA 2022-1040 (February 2022 prioritization guidance).
The fraud and fraudulent statements information has been updated to include information for NIOSH approval holders that the marks N95, N99, N100, P95, P100, the NIOSH logo, and the term “NIOSH-approved” have been recorded as certification marks.
NIOSH RESPIRATOR APPROVAL PROGRAM CERTIFICATION MARKS
The marks N95, N99, N100, P95, P100, the NIOSH logo, and the term “NIOSH-approved” have been recorded with the U.S. Patent and Trademark Office (USPTO) as certification marks. NIOSH, as the certifying federal entity for the Respirator Approval Program, owns the certification marks meaning that NIOSH controls who can use the marks. Accordingly, NIOSH allows approval holders to use these certification marks only if their respirators meet NIOSH’s regulatory standards set forth in Title 42, Part 84, of the Code of Federal Regulations (42 C.F.R. Part 84).
While these marks have historically been protected under common law (as opposed to a trademark registration), these marks are now registered with the USPTO, as federal registrations, as well as in various foreign countries and are subject to additional protections under the Lanham Act, 15 U.S.C. §§ 1051 et seq. and foreign trademark laws. Thus, any misuse of the aforementioned marks, on products released to the market, *including respirators that have failed to satisfy NIOSH’s regulatory requirements or have not received NIOSH approval*, is a direct violation of applicable trademark law and NIOSH may pursue action as necessary.
FRAUD AND FRAUDULENT STATEMENTS
If the NIOSH Respirator Approval Program determines, at any time, that an applicant[1] or a third party acting on behalf of the applicant has engaged in any of the following:
making any materially false, fictitious, or fraudulent statement or representation, including any omission or concealment of substantive fact in any application or application-related material or communication; or
misrepresenting or misusing the NIOSH manufacturers’ code, respirator approval number, or NIOSH title or logo; or
misrepresenting or misusing certification marks including the term “NIOSH-approved” and the NIOSH particulate protections N95, N99, N100, P95, and P100,the NIOSH Respirator Approval Program **will discontinue the processing of any current application for a certificate of approval from the applicant**for the duration of the HHS COVID-19 public health emergency declaration first issued on January 31, 2020[2] and **will not process any new application for a certificate of approval** **from the applicant** for that same time period.
Information concerning suspected fraud related to the NIOSH Respirator Approval Program will be reported to the Department of Health and Human Services’ Office of Inspector General (OIG).  Any person who knowingly and willfully makes any false statement, misrepresentation, concealment of fact, or any other act of fraud to obtain any benefit from the NIOSH Respirator Approval Program is subject to civil and/or administrative remedies as well as felony criminal prosecution and may, under appropriate criminal provisions, be punished by a fine or imprisonment or both pursuant to 18 U.S.C. § 1001.
Additionally, due to ongoing, heightened concerns over fraud and misrepresentation, NIOSH will not respond to emails that lack recognizable company domains. Examples include emails that look like 3894876@hotnet.net, cv2009@vip.126.com, or 3273865@qq.com. NIOSH will only respond to inquiries concerning an approval application or request from an email address recognizably associated with a legitimate business or stakeholder.
[1] “Applicant” means an individual, partnership, company, corporation, association, or other organization that designs, manufactures, assembles, or controls the assembly of a respirator and who seeks to obtain a certificate of approval for such respirator. *See* 42 C.F.R. § 84.2.
[2] *See* https://www.phe.gov/emergency/news/healthactions/phe/Pages/default.aspxexternal icon for the most current *Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic*.Effective Immediately – NIOSH fraud and fraudulent statements policy and new information about using NIOSH marks. This notice and NIOSH CA 2022-1040 supersede NIOSH CA 2021-1032pdf icon [PDF – 238 KB]
							
					
						Page last reviewed:  February 25, 2022					Content source: 	National Institute for Occupational Safety and Health homeNPPTL
What’s New on the NPPTL Websiteplus icon
NPPTL What’s New Archives
A to Z Index
Respiratory Protection Videos
Resources for Mine Workers
Resources for Emergency Responders
Respirator Approval Programplus icon
Respirator Approval Information
Respirator Standards
Respirator User Notices
Resources and Technical Support
Post-market Evaluationsplus icon
PPE CASE Reports
PPE CASE Notes
Respirator Assessments to Support COVID-19 Responseplus icon
Beyond Shelf Life/Stockpiled Assessment Results
International Assessment Results
Decontaminated Assessment Results
Non-NIOSH Approved Innovative Filtering Facepiece Respirator Assessment Results
Protective Clothing and Ensembles
Personal Protective Technology Program
NIOSH Respiratory Protection Week 2023
NPPTL Infographics
NPPTL Fact Sheets
Healthcare Respiratory Protection Resourceplus icon
Policies and Procedures
Program Administrator
Evaluation and Selection
Medical Evaluation
Fit Testing
Proper Use and Storage
Training
Program Evaluation
Recordkeeping
Support for Firefighter Personal Protective Equipmentplus icon
Self-Contained Breathing Apparatusplus icon
Program Overview
Evaluation Process
Completed Reports
Resources
Firefighter Turnout Gearplus icon
Current Projects
Completed Projects
Participation on Standards Setting Organizations
Resources
Considerations for Selecting Protective Clothing
NPPTL Participation in Standard Development Committees
Respiratory Protection Information Trusted Sourceplus icon
Types of Respiratory Protection
Use of NIOSH-approved Respirators
Frequently Asked Questionsplus icon
Respirator FAQs
Fit Test FAQs
NIOSH Approval FAQs
Healthcare Setting Specific FAQs
Approved Particulate Filtering Facepiece Respirators
Certified Equipment List (CEL)
PPE CASE Reports
Respirator User Notices
Meetings, Webinars, & Conferencesplus icon
Archived Meetings and Conferences
Conformity Assessment Notices and Letters to Respirator Manufacturers and Interested Parties
About NPPTL
Contact NPPTL Connect with NPPTL Subscribe to Listserv
PPE concerns? Contact Us
 Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue